Table 2 Tumoral regression among 89 resected patients
A (BVZ + CAPE + RT) (N = 44) | B (CAPE + RT) (N = 46) | Total (N = 90) | P Value Test | ||
|---|---|---|---|---|---|
Pathologic response per tumoral regression (TRG)* | |||||
TRG 1(Complete pathologic response) | N(%) | 8 (18.18) | 5 (10.87) | 13 (14.44) | Fisher: 0.1458 |
TRG 2 | N(%) | 8 (18.18) | 15 (32.61) | 23 (25.56) | |
TRG 3 | N(%) | 14 (31.82) | 19 (41.30) | 33 (36.67) | |
TRG 4 | N(%) | 12 (27.27) | 6 (13.04) | 18 (20.00) | |
TRG 5(Disease progression) | N(%) | 0 (0.00) | 1 (2.17) | 1 (1.11) | |
ND | N(%) | 1 (2.27) | 0 (0.00) | 1 (1.11) | |
Missing | N(%) | 1 (2.27) | 0 (0.00) | 1 (1.11) | |
ypT improvement | |||||
Better | N(%) | 26 (59.09) | 18 (39.13) | 44 (48.89) | Fisher: 0.0429 |
Remained the same | N(%) | 16 (36.36) | 28 (60.87) | 44 (48.89) | |
Worse | N(%) | 1 (2.27) | 0 (0.00) | 1 (1.11) | |
Missing | N(%) | 1 (2.27) | 0 (0.00) | 1 (1.11) | |
ypN improvement | |||||
Better | N(%) | 24 (54.55) | 35 (76.09) | 59 (65.56) | Fisher: 0.0865 |
Remained the same | N(%) | 15 (34.09) | 8 (17.39) | 23 (25.56) | |
Worse | N(%) | 4 (9.09) | 2 (4.35) | 6 (6.67) | |
No evaluable* | N(%) | 0 (0.00) | 1 (2.17) | 1 (1.11) | |
Missing | N(%) | 1 (2.27) | 0 (0.00) | 1 (1.11) | |
ypT and ypN improvement | |||||
Improvement in both | N(%) | 18 (40.91) | 16 (34.78) | 34 (37.78) | Fisher: 0.5612 |
Improvement in one | N(%) | 14 (31.82) | 20 (43.48) | 34 (37.78) | |
No improvement | N(%) | 11 (25.00) | 9 (19.57) | 20 (22.22) | |
Non-evaluable* | N(%) | 0 (0.00) | 1 (2.17) | 1 (1.11) | |
Missing | N(%) | 1 (2.27) | 0 (0.00) | 1 (1.11) | |